In this article, we detail the experience with immune checkpoint inhibitors in patients with autoimmune disease.
Kathryn E. Beckermann, MD, PhD
Advertisement
Articles by Kathryn E. Beckermann, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Toxicity From CD19, BCMA Therapy May Inform B-Cell Malignancy Surveillance
2
Sac-TMT Significantly Improves PFS/OS in Pretreated Endometrial Cancer
3
Nogapendekin Alfa Plus BCG Exhibits Efficacy Advantage in NMIBC In Situ
4
Fianlimab Combo Does Not Significantly Improve PFS in Advanced Melanoma
5